Log in to save to my catalogue

Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine

Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3417327

Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine

About this item

Full title

Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine

Publisher

Oxford: The University of Chicago Press

Journal title

The Journal of infectious diseases, 2009-08, Vol.200 (4), p.501-508

Language

English

Formats

Publication information

Publisher

Oxford: The University of Chicago Press

More information

Scope and Contents

Contents

BackgroundH5N1 avian influenza represents an episodic zoonotic disease with the potential to cause a pandemic, and antiviral resistance is of considerable concern. We sought to generate high-titer H5N1 antibodies in healthy volunteers for the purpose of developing hyperimmune intravenous immunoglobulin MethodsWe conducted a dose-escalating, unblind...

Alternative Titles

Full title

Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3417327

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3417327

Other Identifiers

ISSN

0022-1899

E-ISSN

1537-6613

DOI

10.1086/599992

How to access this item